resTORbio to Participate at Upcoming Investor Conferences in May

BOSTON, May 01, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. TORC, a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat aging-related diseases, today announced that company management will participate in two investor conferences in May:

SunTrust Robinson Humphrey 5^th Annual Life Sciences Summit

Date: Tuesday, May 7, 2019

Location: New York, NY

Bank of America Merrill Lynch 2019 Health Care Conference

Date: Wednesday, May 15, 2019

Presentation Time: 3:55 p.m. PT (6:55 p.m. ET)

Location: Las Vegas, NV

A live audio webcast of the Bank of America Merrill Lynch Health Care Conference presentation can be accessed on the Investors section of resTORbio's website at http://ir.restorbio.com/investors. An archived replay will be available for at least 30 days following the presentation.

About resTORbio

resTORbio, Inc. is a clinical stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat aging-related diseases. resTORbio's lead program selectively inhibits TORC1, an evolutionarily conserved pathway that contributes to the decline in function of multiple organ systems, including the immune, cardiovascular and central nervous systems.

Investor Contact

Michael Schaffzin

Stern Investor Relations, Inc.

212-362-1200

michael.schaffzin@sternir.com

Media Contact

Amir Khan

Biosector 2

212-462-8767

Amir.Khan@Syneoshealth.com